The global computational biology market size was US$ 5.5 billion in 2021. The global computational biology market size is estimated to reach US$ 27.3 billion by 2030, growing at a compound annual growth rate (CAGR) of 19.5% during the forecast period from 2022 to 2030.
Computational biology is a unit of biology that uses computers and computer science to understand better and mimic the biological structures and functions of life. It involves the use of computational approaches for the simulation and representation of biological systems and the interpretation of large-scale experimental data. It is an interdisciplinary area that creates and involves computational methods to examine large groups of biological data, such as cell populations, or protein models, as genetic sequences to discover new biology or to make new predictions. It also contains analytical techniques such as simulation and mathematical modeling.
Factors Affecting Market Growth
An increase in the adoption of advanced software and development and a rise in demand for pharmacovigilance for drug discovery boost the global market.
The rise in demand for devices of computational biology in different fields such as proteomics, epi-genomics, genomics, and meta-genomics for a more suitable understanding of protein structure drives the global market.
Lack of standardization, high initial cost and maintenance costs of the tools, and lack of qualified workforce are anticipated to hinder the global market.
Virtual cell open-source software, computer genomics, and computational proteomics increase the demand for many private and commercial cloud platforms that work closely with government and public entities to provide biological and cellular simulation is anticipated to drive the global market.
Impact Analysis of COVID-19
The COVID-19 pandemic had a negative impact on the global market. In order to restrain the spread of COVID-19, governments enforced strict regulations such as lockdowns, border locks, and strict social distancing steps. These steps had a considerable result on the global economy, impacting various industries. Biotech and Pharmaceutical companies working together with governments to tackle the COVID-19 situation by supporting the growth of vaccines to planning for medicine supply chain challenges.
North America was the dominant shareholder in the global market in 2021. With a rise in demand for pharmacovigilance to conduct clinical trials and for pre-clinical drug expansion, confirming government initiatives, R&D investments are the primary elements that boost the growth of the global market.
LAMEA is anticipated to grow most rapidly during the forecast period. The increase in demand for bioinformatics tools and services, increase in the number of product approval and rise in the number of clinical trial procedures, stress key players in improving their existence and thus boost the global market in the region.
The prominent players in the computational biology market are:
Rhenovia Pharma SAS & Leadscope Inc.
Nimbus Discovery LLC
Rhenovia Pharma SAS
Insilico Biotechnology AG
Simulation Plus Inc
Chemical Computing Group Inc
The global computational biology market focuses on Applications, Services, End Use, and Region.
Segmentation on the basis of Applications
Human Body Simulation Software
Preclinical Drug Development
Drug Discovery and Disease Modeling
Cellular and Biological Modelling
Segmentation on the basis of Services
Segmentation on the basis of End Use
Academics and Research
Segmentation on the basis of Region
Rest of Western Europe
Rest of Eastern Europe
Australia & New Zealand
Rest of Asia Pacific
Middle East & Africa (MEA)
Rest of MEA
Rest of South America